María Poca

4.1k total citations · 2 hit papers
50 papers, 2.4k citations indexed

About

María Poca is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, María Poca has authored 50 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 28 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in María Poca's work include Liver Disease and Transplantation (36 papers), Liver Disease Diagnosis and Treatment (27 papers) and Organ Transplantation Techniques and Outcomes (9 papers). María Poca is often cited by papers focused on Liver Disease and Transplantation (36 papers), Liver Disease Diagnosis and Treatment (27 papers) and Organ Transplantation Techniques and Outcomes (9 papers). María Poca collaborates with scholars based in Spain, Switzerland and Canada. María Poca's co-authors include Càndid Villanueva, Carles Aracil, Carlos Guarner, Virginia Hernández–Gea, Isabel Graupera, Alan Colomo, Mar Concepción, Carlos Guarner‐Argente, Jordi Gordillo and Cristina Álvarez–Urturi and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

María Poca

48 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transfusion Strategies for Acute Upper Gastrointestinal Bleeding

2013 1.0k citations Càndid Villanueva, Alan Colomo et al. profile →
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

2019 392 citations Càndid Villanueva, Agustı́n Albillos et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
María Poca Spain	18	1.4k	1.4k	939	467	306	50	2.4k
Carles Aracil Spain	19	2.0k 1.4×	1.9k 1.4×	1.4k 1.5×	466 1.0×	295 1.0×	36	3.0k
Jordi Gordillo Spain	6	350 0.2×	346 0.3×	404 0.4×	466 1.0×	298 1.0×	9	1.2k
Annabel Blasi Spain	22	747 0.5×	599 0.4×	635 0.7×	123 0.3×	344 1.1×	83	1.4k
Càndid Villanueva Spain	36	5.3k 3.7×	4.8k 3.5×	3.4k 3.6×	477 1.0×	391 1.3×	98	7.1k
Patrick G. Northup United States	38	3.7k 2.6×	3.0k 2.2×	2.3k 2.4×	54 0.1×	439 1.4×	122	5.2k
Adrian J. Stanley United Kingdom	39	2.7k 1.9×	2.6k 1.9×	2.8k 3.0×	58 0.1×	92 0.3×	178	5.4k
Franklin A. Bontempo United States	25	659 0.5×	418 0.3×	778 0.8×	242 0.5×	457 1.5×	51	2.1k
M. Cazzaniga Italy	18	1.9k 1.4×	1.7k 1.3×	866 0.9×	25 0.1×	203 0.7×	35	2.3k
Eduardo Jaurrieta Spain	35	1.8k 1.2×	810 0.6×	3.0k 3.1×	82 0.2×	143 0.5×	153	4.2k
Ammar Majeed Australia	22	281 0.2×	556 0.4×	491 0.5×	49 0.1×	160 0.5×	96	2.2k

Countries citing papers authored by María Poca

Since Specialization

Citations

This map shows the geographic impact of María Poca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Poca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Poca more than expected).

Fields of papers citing papers by María Poca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Poca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Poca. The network helps show where María Poca may publish in the future.

Co-authorship network of co-authors of María Poca

This figure shows the co-authorship network connecting the top 25 collaborators of María Poca. A scholar is included among the top collaborators of María Poca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Poca. María Poca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poca, María, Eva Román, Marta Puerto, et al.. (2025). Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis. Nutrients. 17(2). 226–226. 2 indexed citations

Poca, María, Eva Román, Cristina Velasco, et al.. (2025). Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty. Medical Sciences. 13(1). 30–30. 1 indexed citations

Alvarado‐Tápias, Edilmar, Anna Brujats, Ángela Puente, et al.. (2024). Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized trial. Hepatology. 82(1). 140–154. 6 indexed citations

Ardèvol, Alba, Víctor Sapena, Edilmar Alvarado‐Tápias, et al.. (2024). Influence of further decompensation on survival across clinical stages of decompensated cirrhosis: The role of portal hypertension and HVPG changes. Liver International. 44(8). 1971–1989. 4 indexed citations

Villanueva, Càndid, Joan Genescà, Juan Carlos García‐Pagán, et al.. (2024). Progressive systemic inflammation precedes decompensation in compensated cirrhosis. JHEP Reports. 7(2). 101231–101231. 4 indexed citations

Poca, María, Edilmar Alvarado‐Tápias, Anna Brujats, et al.. (2024). Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis: a retrospective study. Scientific Reports. 14(1). 2718–2718.

Villanueva, Càndid, Agustı́n Albillos, Joan Genescà, et al.. (2021). Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. Journal of Hepatology. 75(3). 589–599. 39 indexed citations

Brujats, Anna, Mar Concepción, Jordi Gordillo, et al.. (2021). Predictors of the need for necrosectomy in patients with walled-off pancreatic necrosis treated with lumen apposition metal stents. Surgical Endoscopy. 36(2). 1339–1346. 1 indexed citations

Alvarado‐Tápias, Edilmar, Alba Ardèvol, Oana Pavel, et al.. (2020). Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis. Journal of Hepatology. 73(4). 829–841. 36 indexed citations

10.

Villanueva, Càndid, Agustı́n Albillos, Joan Genescà, et al.. (2019). β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 393(10181). 1597–1608. 392 indexed citations breakdown →

11.

Alvarado‐Tápias, Edilmar, Carlos Guarner‐Argente, Elisabet Sánchez, et al.. (2018). Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites. World Journal of Hepatology. 10(1). 124–133. 6 indexed citations

12.

Villanueva, Càndid, Agustı́n Albillos, Joan Genescà, et al.. (2015). Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension. Hepatology. 63(1). 197–206. 132 indexed citations

13.

Rodríguez, Ezequiel, Chiara Elia, Elsa Solà, et al.. (2014). Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis. Journal of Hepatology. 60(5). 955–961. 84 indexed citations

14.

Puente, Ángela, Virginia Hernández–Gea, Isabel Graupera, et al.. (2013). Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver International. 34(6). 823–833. 84 indexed citations

15.

Marinello, Franco, Eduardo M. Targarona, Carmen Balagué, et al.. (2013). Abordaje laparoscópico de la acalasia. Resultados clínicos, de calidad de vida y funcionales a largo plazo. Cirugía Española. 92(3). 188–194. 3 indexed citations

16.

Poca, María, Mar Concepción, Meritxell Casas, et al.. (2011). Role of Albumin Treatment in Patients With Spontaneous Bacterial Peritonitis. Clinical Gastroenterology and Hepatology. 10(3). 309–315. 46 indexed citations

17.

Soriano, Germán, Eva Román, Joan Córdoba, et al.. (2011). Cognitive dysfunction in cirrhosis is associated with falls: A prospective study. Hepatology. 55(6). 1922–1930. 88 indexed citations

18.

Guarner‐Argente, Carlos, María Poca, Sergio Sáinz, et al.. (2010). Cholangitis caused by biliary hydatidosis. Gastrointestinal Endoscopy. 72(6). 1264–1266. 3 indexed citations

19.

Guarner‐Argente, Carlos, Elisabet Sánchez, Sílvia Vidal, et al.. (2010). Toll‐like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients. Alimentary Pharmacology & Therapeutics. 31(11). 1192–1199. 29 indexed citations

20.

Carrión, Sílvia, E. García‐Planella, Míriam Mañosa, et al.. (2009). P143 - Influence of smoking on azathioprine efficacy in steroid-dependent inflammatory bowel disease. Journal of Crohn s and Colitis. 3(1). S67–S68. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact